Home Chemo Free Regiment Karolinska University Study Shows Chemo-Free Regimen Feasible for Indolent Lymphoma

Karolinska University Study Shows Chemo-Free Regimen Feasible for Indolent Lymphoma

606
0

University of Karolinska and other Nordic researchers reveal that more than a third of patients with symptomatic indolent lymphoma required no chemotherapy during more than 10 years of follow-up after initial treatment with Roche’s (rituximab (Rituxan).

Lead Research/Investigator

Sandra Lockmer, MD, of Karolinska University

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.